CHGA (CHGA) Stock Price & Analysis
CHGA (CHGA) fell 0.83% to USD 2.4 as of September 8, 2026 at 16:21 UTC, according to Nexqual real-time market data.
CHGA last closed at USD 2.4; the session ranged USD 2.38–2.41 on volume of 14,043 shares. Market capitalization is —, with a 52-week range of USD 2.29–57.98 (NCM). Source: Nexqual, September 8, 2026 at 16:21 UTC.
Key Statistics (as of September 8, 2026 at 16:21 UTC)
| Price | USD 2.4 |
|---|---|
| Change | ▼ 0.83% (down) |
| Previous Close | USD 2.4 |
| Open | USD 2.4 |
| Day Range | USD 2.38 – 2.41 |
| 52-Week Range | USD 2.29 – 57.98 |
| Volume | 14,043 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CHGA)
Nexqual's technical model rates CHGA "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.2 (oversold) |
| vs SMA50 | Below (USD 4.34) |
| MACD | -0.58 (negative) |
From CHGA's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals, Inc | USD 6.83 | ▲ 2.55% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 3.58 | ▼ 15.79% |
| ATXI | Avenue Therapeutics, Inc. | USD 0.54 | ▼ 5.26% |
| TRNR | Interactive Strength Inc. | USD 2.88 | ▼ 0.62% |
| EDSA | Edesa Biotech, Inc. | USD 4.85 | ▲ 1.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:21 UTC. This page is informational and not investment advice.